Literature DB >> 7545239

Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.

M J Goldman1, J M Wilson.   

Abstract

Recombinant adenoviruses are being evaluated for gene therapy of cystic fibrosis lung disease with the goal of reconstituting the expression of the cystic fibrosis transmembrane conductance regulator in pulmonary epithelia by direct administration of the virus into the airway. The therapeutic potential of recombinant adenoviruses is limited in part by the relative inefficiency by which gene transfer occurs. This study uses a human bronchial xenograft model to study adenovirus infection in the human airway in an attempt to define the molecular events that limit gene transfer. Our studies of the human airway confirm previous observations of cell lines that have indicated a two-step process for adenovirus entry, which begins with the binding of the virus to the cell through the fiber protein and continues with internalization via interactions among cellular integrins and an RGD motif (Arg-Gly-Asp) in the penton base. Furthermore, the level of maturity of the epithelia in xenografts has a major impact on gene transfer. Undifferentiated epithelia express high levels of alpha v beta 5 integrins and are easily infected with recombinant adenoviruses; gene transfer is completely inhibited with excess fiber and partially inhibited with RGD peptide and alpha v beta 5 integrin antibody. Pseudostratified epithelia do not express alpha v beta 5 integrin in differentiated columnar cells and are relatively resistant to adenovirus-mediated gene transfer; what little gene transfer occurs is inhibited by fiber but not by RGD peptide or alpha v beta 5 integrin antibody. These studies suggest that the expression of integrins in human airway epithelia limits the efficiency of gene transfer with recombinant adenoviruses. However, low-level gene transfer can occur in fully mature epithelia through alpha v beta 5 integrin-independent pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545239      PMCID: PMC189490     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

Authors:  J F Engelhardt; Y Yang; L D Stratford-Perricaudet; E D Allen; K Kozarsky; M Perricaudet; J R Yankaskas; J M Wilson
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

2.  Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.

Authors:  J Zabner; D M Petersen; A P Puga; S M Graham; L A Couture; L D Keyes; M J Lukason; J A St George; R J Gregory; A E Smith
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

3.  Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Authors:  J F Engelhardt; R H Simon; Y Yang; M Zepeda; S Weber-Pendleton; B Doranz; M Grossman; J M Wilson
Journal:  Hum Gene Ther       Date:  1993-12       Impact factor: 5.695

4.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

5.  Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo.

Authors:  S A Mette; J Pilewski; C A Buck; S M Albelda
Journal:  Am J Respir Cell Mol Biol       Date:  1993-05       Impact factor: 6.914

6.  Distribution of integrin cell adhesion receptors in normal and malignant lung tissue.

Authors:  L Damjanovich; S M Albelda; S A Mette; C A Buck
Journal:  Am J Respir Cell Mol Biol       Date:  1992-02       Impact factor: 6.914

7.  Stepwise dismantling of adenovirus 2 during entry into cells.

Authors:  U F Greber; M Willetts; P Webster; A Helenius
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

8.  Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells.

Authors:  M Bai; B Harfe; P Freimuth
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

Authors:  M A Rosenfeld; K Yoshimura; B C Trapnell; K Yoneyama; E R Rosenthal; W Dalemans; M Fukayama; J Bargon; L E Stier; L Stratford-Perricaudet
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2.

Authors:  M Bai; L Campisi; P Freimuth
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  45 in total

1.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta5.

Authors:  K Wang; T Guan; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

Authors:  C L Halbert; T A Standaert; M L Aitken; I E Alexander; D W Russell; A D Miller
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Adenoviral transfer of HSP-70 into pulmonary epithelium ameliorates experimental acute respiratory distress syndrome.

Authors:  Yoram G Weiss; Alina Maloyan; John Tazelaar; Nichelle Raj; Clifford S Deutschman
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

5.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

6.  Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

Authors:  Lena J Gamble; Hideyo Ugai; Minghui Wang; Anton V Borovjagin; Qiana L Matthews
Journal:  J Mol Biochem       Date:  2012-02-15

7.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

8.  Engineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an example.

Authors:  Quinn K T Ng; Marie K Sutton; Pan Soonsawad; Li Xing; Holland Cheng; Tatiana Segura
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

9.  Interactions of soluble recombinant integrin alphav beta5 with human adenoviruses.

Authors:  P Mathias; M Galleno; G R Nemerow
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer.

Authors:  R J Pickles; D McCarty; H Matsui; P J Hart; S H Randell; R C Boucher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.